Nasdaq Inc Stock Price, News & Analysis

On December 11, 2020, Nasdaq (NDAQ) announced the reconstitution of the Nasdaq Biotechnology Index (NBI), effective December 21, 2020. This annual adjustment will include 100 new biotech and pharmaceutical securities, enhancing the index's representation in the sector. Notable additions are Arbutus Biopharma, Adaptimmune Therapeutics, and BioNTech, among others. Conversely, 16 securities will be removed from the index, including ADMA Biologics and Myris, Inc. The changes aim to better reflect market trends and advance investor insights into the biotech landscape.

Nasdaq, Inc. (NDAQ) has announced a public offering totaling $1.9 billion in senior notes with varying maturity dates: $600 million at 0.445% due in 2022, $650 million at 1.650% due in 2031, and $650 million at 2.500% due in 2040. The net proceeds will finance the acquisition of Verafin, cover its outstanding debts, and support general corporate needs. The offering closes on December 21, 2020, pending customary conditions.

Nasdaq, Inc. (NDAQ) announced its plan to offer senior notes, subject to market conditions, to finance its pending acquisition of Verafin Holdings Inc. The expected net proceeds will also be used to repay Verafin's outstanding debts and for general corporate purposes. Major banks, including J.P. Morgan and Goldman Sachs, will manage the Offering. The Offering will be conducted under a previously filed shelf registration with the SEC and will include forward-looking statements about potential risks and market conditions.

Nasdaq (Nasdaq: NDAQ) reported its monthly trading volumes for November 2020, emphasizing its role in global capital markets. The detailed statistics can be accessed via their investor relations website. The company is committed to delivering data, analytics, software, and services to help clients achieve business goals. Nasdaq also included a cautionary note regarding forward-looking statements, acknowledging potential risks such as market fluctuations and regulatory actions, which may impact future performance.

Nasdaq Ventures has announced a strategic investment in Matter, a leading sustainability analysis and reporting provider, enhancing its ESG capabilities. This partnership aims to provide retail and institutional investors with actionable insights into their portfolios’ ESG impacts. Matter's tools analyze performance across over 14,000 global companies, offering benchmarking on various sustainability metrics. Nasdaq’s investment will facilitate the expansion of Matter’s offerings, addressing the growing demand for sustainable investing options and ESG data solutions.

Nasdaq has announced its acquisition of Verafin for US$2.75 billion in cash, enhancing its position as a leading SaaS technology provider in anti-financial crime solutions. Verafin's cloud products deliver approximately 30% compound annual recurring revenue growth within a US$13 billion addressable market. The acquisition is expected to increase Nasdaq's revenue contribution from the Market Technology segment to 47% and enhance its growth outlook to 6-9%.

The deal is projected to add EPS accretion starting in 2022.